Genocea Biosciences (GNCA) Tops Q3 EPS by 15c; Reports Cash and Cash Equivalents of $48.9M

Genocea Biosciences (NASDAQ: GNCA) reported Q3 EPS of ($0.05), $0.15 better than the analyst estimate of ($0.20).

For earnings history and earnings-related data on Genocea Biosciences (GNCA) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• L3Harris CEO steps down amid conduct review, shares drop
• INVO Fertility (IVF) Tops Q2 EPS by 105c